Stockscreener 앱 받기
100.05
1.18%
-1.19
시간 외 거래:
97.00
-3.05
-3.05%
전일 마감가:
$101.24
열려 있는:
$99.71
하루 거래량:
11.75M
Relative Volume:
1.78
시가총액:
$149.74B
수익:
$16.75B
순이익/손실:
$1.85B
주가수익비율:
80.04
EPS:
1.25
순현금흐름:
$2.37B
1주 성능:
-2.24%
1개월 성능:
-3.60%
6개월 성능:
+18.42%
1년 성능:
+48.33%
1일 변동 폭
$98.44
$101.02
1주일 범위
$97.85
$102.24
52주 변동 폭
$66.80
$107.17
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
No benefit found for cerebral protection device in TAVR - BioWorld MedTech
Boston Scientific CEO Michael Mahoney sells $16.4 million in stock - Investing.com
Boston Scientific closes Bolt Medical acquisition - MassDevice
Evercore ISI Adjusts Boston Scientific Price Target to $110 From $112, Maintains Outperform Rating - MarketScreener
FDA Approval Boosts Boston Scientific's (BSX) Investment in Bolt Medical - GuruFocus
FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout - Yahoo
Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires - Insider Monkey
Boston Scientific announces conference call discussing first quarter 2025 results - Financial Times
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
FDA clears Boston Scientific Bolt IVL system - MassDevice
Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system - MassDevice
2024 Research: Urinary Guidewire Market Set to Reach Over $266 Million by 2031, Tech Advancements and Shift Towards Minimally Invasive Surgeries - GlobeNewswire Inc.
Boston Scientific Co. (NYSE:BSX) is Homestead Advisers Corp's 8th Largest Position - MarketBeat
Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance
Boston Scientific to acquire SoniVie - Today's Medical Developments
$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today - Benzinga
International Expansion, Product Launches Support BSX Stock - Yahoo Finance
Goldman Sachs Adjusts Price Target on Boston Scientific to $116 From $119, Maintains Buy Rating - Marketscreener.com
The Zacks Analyst Blog Highlights Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace - Yahoo Finance
Top Stock Reports for Tesla, Home Depot & Boston Scientific - MSN
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Boston Scientific SVP Vance Brown sells shares worth $486,702 By Investing.com - Investing.com Australia
Market Makes A Big Shift: DoorDash, Heico, Boston Scientific In Focus - Investor's Business Daily
Boston Scientific SVP Vance Brown sells shares worth $486,702 - Investing.com India
Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX) - Yahoo Finance
Boston Scientific CEO joins the $20M compensation club - NBC Boston
Boston Scientific CEO gets 14% boost in compensation - The Business Journals
November 21st Options Now Available For Boston Scientific (BSX) - Nasdaq
RBC Capital maintains Outperform on Boston Scientific shares, $116 target - Investing.com
Investors more bullish on Boston Scientific (NYSE:BSX) this week as stock grows 5.6%, despite earnings trending downwards over past five years - Yahoo Finance
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Boston Scientific Corporation Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – BSX - Business Wire
Form DEF 14A BOSTON SCIENTIFIC CORP For: Mar 19 - StreetInsider
Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360
Is Boston Scientific Corporation (BSX) the Top Stock to Buy According to Marshall Wace LLP? - Insider Monkey
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Neurotech Devices Market Is Booming Worldwide 2025-2032 | - openPR
Here's Why We Think Boston Scientific (NYSE:BSX) Is Well Worth Watching - Yahoo Finance
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? - Yahoo Finance
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth By Investing.com - Investing.com South Africa
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report - Yahoo Finance
Boston Scientific Gains 42.2% in a Year: What's Driving the Stock? - Yahoo Finance
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Finance
Boston Scientific (BSX) Down 4% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
4C raises $175M for mitral valve technology - BioWorld Online
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
How Boston Scientific (sort of) became ‘Minnesota Scientific’ - Star Tribune
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
0.26%
자본화:
|
볼륨(24시간):